Cat allergy immunotherapy - NIOX
Alternative Names: Cat allergen vaccine - NIOX; Cat peptide allergen desensitisation; Cat Synthetic Peptide Immuno-Regulatory Epitopes; Cat-PAD; Cat-SPIRE; ToleroMune; ToleroMune CatLatest Information Update: 29 Jun 2023
Price :
$50 *
At a glance
- Originator Circassia
- Developer NIOX
- Class Allergens; Antiallergics; Cat allergy immunotherapies; Peptide vaccines; Peptides
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Allergic rhinoconjunctivitis; Hypersensitivity
Most Recent Events
- 01 Apr 2021 Discontinued - Phase-II for Allergic rhinoconjunctivitis (In children) in USA, Poland (Intradermal)
- 01 Apr 2021 Discontinued - Phase-III for Allergic rhinoconjunctivitis in Germany (Intradermal)
- 01 Apr 2021 Discontinued - Phase-III for Allergic rhinoconjunctivitis in Slovakia, Russia, Poland, Belgium, Canada, Czech Republic, Hungary, USA (Intradermal)